Versão BETA

Acesso livre
Acesso livre

Neurologia

Comentário sobre estudo | História da hipotermia na parada cardíaca, 2002-2021 (RIP).

18 Jun, 2021 | 10:29h

A history of hypothermia for cardiac arrest, 2002-2021 (RIP) – PulmCrit

Estudo original: RCT: In patients with coma after out-of-hospital cardiac arrest, targeted hypothermia did not improve outcomes.

 

Comentário no Twitter

 


M-A | Tratamentos agudos para enxaqueca episódica em adultos.

18 Jun, 2021 | 10:28h

Acute Treatments for Episodic Migraine in Adults: A Systematic Review and Meta-analysis – JAMA (gratuito por tempo limitado)

Editorial: Acute Treatment for Migraine: Contemporary Treatments and Future Directions (gratuito por tempo limitado)

 

Comentário no Twitter (fio – clique para saber mais)

 


Estudo randomizado | Efeitos do eptinezumabe intravenoso vs. placebo sobre a cefaleia e outros sintomas quando administrado no início de uma crise de enxaqueca.

18 Jun, 2021 | 10:27h

Effects of Intraven.ous Eptinezumab vs Placebo on Headache Pain and Most Bothersome Symptom When Initiated During a Migraine Attack: A Randomized Clinical Trial – JAMA (gratuito por tempo limitado)

Editorial: Acute Treatment for Migraine: Contemporary Treatments and Future Directions (gratuito por tempo limitado)

Comentário: Migraine Prevention Drug Eptinezumab Shows Efficacy in Treating Acute Attacks – Physician’s Weekly

 

Comentário no Twitter (fio – clique para saber mais)

 


Estudo randomizado | Em paciente em coma após parada cardíaca fora do ambiente hospitalar, a hipotermia induzida não melhorou os desfechos.

17 Jun, 2021 | 10:56h

Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest – New England Journal of Medicine

Comunicado de imprensa: Induced hypothermia after cardiac arrest did not improve survival – Lund University

Infográfico: The TTM2 Trial – CanadianEM

Comentário: Hypothermia or Normothermia after Cardiac Arrest – NEJM Resident 360

Vídeo: TTM2 Results Presentation Livestream – Critical Care Reviews

 

Comentário no Twitter (fio – clique para saber mais)

 


Estudo randomizado | Estimulação nervosa periférica percutânea (neuromodulação) para dor pós-cirúrgica.

16 Jun, 2021 | 10:47h

Percutaneous Peripheral Nerve Stimulation (Neuromodulation) for Postoperative Pain: A Randomized, Sham-controlled Pilot Study – Anesthesiology

Comentário: Peripheral Nerve Stimulation May Cut Pain After Orthopedic Surgery – HealthDay


Revisão sistemática | Trombectomia endovascular e intervenções intra-arteriais para acidente vascular cerebral isquêmico agudo – “Em pacientes com AVC isquêmico causado por oclusão de grandes artérias na circulação anterior, a trombectomia endovascular pode aumentar a chance de sobrevida com bom desfecho funcional.”

15 Jun, 2021 | 11:16h

Endovascular thrombectomy and intra‐arterial interventions for acute ischaemic stroke – Cochrane Library

Resumo: Endovascular thrombectomy for acute ischaemic stroke – Cochrane Library


M-A | Eficácia da telerreabilitação na prática da fisioterapia.

10 Jun, 2021 | 08:57h

Effectiveness of Telerehabilitation in Physical Therapist Practice: An Umbrella and Mapping Review With Meta–Meta-Analysis – Physical Therapy & Rehabilitation Journal


Aprovação do FDA para medicamento contra o Alzheimer gera controvérsia entre médicos.

9 Jun, 2021 | 09:49h

Comunicado de imprensa: FDA Grants Accelerated Approval for Alzheimer’s Drug – U.S. Food & Drug Administration

Comentários: ICER Issues Statement on the FDA’s Approval of Aducanumab for Alzheimer’s Disease – Institute for Clinical and Economic Review E Landmark Alzheimer’s Drug Approval Confounds Research Community – Nature E FDA approves Alzheimer’s drug from Biogen, against experts’ advice – NBC News E F.D.A. Approves Alzheimer’s Drug Despite Fierce Debate Over Whether It Works – The New York Times (alguns artigos gratuitos por mês) E Alzheimer’s drug approved despite doubts about effectiveness – Science (alguns artigos gratuitos por mês) E The FDA Has Approved A New Alzheimer’s Drug — Here’s Why That’s Controversial – NPR E Opinion: Bad medicine: aducanumab is a lackluster drug with a high price tag – STAT


Pequena revisão | Complicações neurológicas da COVID-19.

8 Jun, 2021 | 10:30h

Neurological complications of COVID-19 – Intensive Care Medicine

 

Comentário no Twitter

 


2 novas metanálises detalham as condições neurológicas e psiquiátricas causadas pela COVID-19.

7 Jun, 2021 | 10:26h

Neurologic, psychiatric conditions common in COVID-19 – CIDRAP

Metanálise 1: Neurology and neuropsychiatry of COVID-19: a systematic review and meta-analysis of the early literature reveals frequent CNS manifestations and key emerging narratives – Journal of Neurology, Neurosurgery & Psychiatry

Metanálise 2: Central and peripheral nervous system involvement by COVID-19: a systematic review of the pathophysiology, clinical manifestations, neuropathology, neuroimaging, electrophysiology, and cerebrospinal fluid findings – BMC Infectious Diseases

Relacionado: Large study finds 1 in 3 Covid-19 survivors have subsequent mental health and neurological conditions


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.